Literature DB >> 29863249

MiR-431 inhibits colorectal cancer cell invasion via repressing CUL4B.

W-B Su1, Z-Y Liu.   

Abstract

OBJECTIVE: To detect the expression of microRNA-431 (miR-431) in epithelial-mesenchymal transition (EMT) in colorectal carcinoma and investigate its effects on the migration of colorectal cancer cells. PATIENTS AND METHODS: MiR-431 expressions in colorectal cancer tissues and adjacent tissues were examined via Real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR). The expression levels of cullin-4B (CUL4B) and EMT-related protein were evaluated by Western blotting assay. The invasive ability of the cells was examined via transwell method.
RESULTS: The expression level of miR-431 in colorectal cancer tissues was lower than that in adjacent tissues (p<0.05). After colorectal cancer cell line was transfected with miR-431 mimics, the expression level of e-cadherin was increased in the cells, and the expression levels of n-cadherin, vimentin, fibronectin (FN), and snail were reduced (p<0.05). The migration ability of colorectal cancer cells with miR-431 overexpression was significantly decreased. Moreover, the reverse effect was observed in cells transfected with miR-431 inhibitors.
CONCLUSIONS: The low expression of miR-431 in colorectal cancer patients is involved in the development of colorectal cancer by promoting the migration of colorectal cancer cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29863249     DOI: 10.26355/eurrev_201805_15062

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  9 in total

1.  MicroRNA-431-5p Inhibits the Tumorigenesis of Osteosarcoma Through Targeting PANX3.

Authors:  Shengliang Sun; Lei Fu; Gen Wang; Jianli Wang; Liping Xu
Journal:  Cancer Manag Res       Date:  2020-09-08       Impact factor: 3.989

2.  miR-431 Promotes Metastasis of Pancreatic Neuroendocrine Tumors by Targeting DAB2 Interacting Protein, a Ras GTPase Activating Protein Tumor Suppressor.

Authors:  Tiantian Zhang; Soyoung Choi; Tuo Zhang; Zhengming Chen; Yudan Chi; Shixia Huang; Jenny Z Xiang; Yi-Chieh Nancy Du
Journal:  Am J Pathol       Date:  2020-01-14       Impact factor: 4.307

3.  microRNA-769 is downregulated in colorectal cancer and inhibits cancer progression by directly targeting cyclin-dependent kinase 1.

Authors:  Lei Wang; Minyi Xu; Pei Lu; Fangfang Zhou
Journal:  Onco Targets Ther       Date:  2018-12-12       Impact factor: 4.147

4.  NCBP1 promotes the development of lung adenocarcinoma through up-regulation of CUL4B.

Authors:  Huijun Zhang; An Wang; Yulong Tan; Shaohua Wang; Qinyun Ma; Xiaofeng Chen; Zelai He
Journal:  J Cell Mol Med       Date:  2019-08-26       Impact factor: 5.310

5.  Biliverdin Reductase A (BLVRA) Promotes Colorectal Cancer Cell Progression by Activating the Wnt/β-Catenin Signaling Pathway.

Authors:  Haiyan Mao; Yuan Xu; Zhengrong Zhang; Guozhuang Sun; Zhu Wang; Dawei Qiao; Xudong Yin; Siping Liu; Ping Bo
Journal:  Cancer Manag Res       Date:  2020-04-23       Impact factor: 3.989

6.  MicroRNA-498 reduces the proliferation and invasion of colorectal cancer cells via targeting Bcl-2.

Authors:  Tongsheng Wang; Ling Ma; Wenxia Li; Lei Ding; Hong Gao
Journal:  FEBS Open Bio       Date:  2019-12-17       Impact factor: 2.693

7.  CircRNA_0005075 suppresses carcinogenesis via regulating miR-431/p53/epithelial-mesenchymal transition axis in gastric cancer.

Authors:  Jiaming Wu; Zhiheng Chen; Yihuan Song; Yi Zhu; Guangjian Dou; Xuning Shen; Yuan Zhou; Honggang Jiang; Jin Li; Yuping Peng
Journal:  Cell Biochem Funct       Date:  2020-03-04       Impact factor: 3.685

8.  The role of human umbilical cord mesenchymal stem cells-derived exosomal microRNA-431-5p in survival and prognosis of colorectal cancer patients.

Authors:  Muwen Qu; Junyi Li; Zifu Hong; Fei Jia; Yinghua He; Lingling Yuan
Journal:  Mutagenesis       Date:  2022-04-23       Impact factor: 2.954

9.  Hypoxia-induced circular RNA hsa_circ_0008450 accelerates hepatocellular cancer progression via the miR-431/AKAP1 axis.

Authors:  Qiajun Du; Jie Han; Shan Gao; Shangdi Zhang; Yunyan Pan
Journal:  Oncol Lett       Date:  2020-10-29       Impact factor: 2.967

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.